1. Home
  2. GLAS vs PHAT Comparison

GLAS vs PHAT Comparison

Compare GLAS & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glass House Brands Inc. Subordinate Voting Shares

GLAS

Glass House Brands Inc. Subordinate Voting Shares

HOLD

Current Price

$4.08

Market Cap

504.2M

Sector

Health Care

ML Signal

HOLD

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

SELL

Current Price

$7.13

Market Cap

590.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
GLAS
PHAT
Founded
2015
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
504.2M
590.6M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
GLAS
PHAT
Price
$4.08
$7.13
Analyst Decision
Strong Buy
Buy
Analyst Count
3
12
Target Price
$16.00
★ $20.45
AVG Volume (30 Days)
★ 1.4M
1.2M
Earning Date
11-11-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 42.72
EPS
★ N/A
N/A
Revenue
N/A
★ $175,110,000.00
Revenue This Year
$8.49
$80.58
Revenue Next Year
$27.75
$56.62
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 216.93
52 Week Low
$4.15
$6.52
52 Week High
$12.70
$18.31

Technical Indicators

Market Signals
Indicator
GLAS
PHAT
Relative Strength Index (RSI) 12.55 40.28
Support Level N/A $6.91
Resistance Level $10.53 $9.74
Average True Range (ATR) 0.52 0.35
MACD -0.18 0.06
Stochastic Oscillator 4.23 45.59

Price Performance

Historical Comparison
GLAS
PHAT

About GLAS Glass House Brands Inc. Subordinate Voting Shares

Glass House Brands Inc is an integrated cannabis company that operates exclusively in the state of California. Its portfolio of brands includes Glass House Farms, Forbidden Flowers, and Mama Sue Wellness. It cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and consumer packaged goods to third-party retail stores. It also owns and operates retail cannabis stores in the state of California. It has three reportable segments: Retail, Wholesale Biomass, and Cannabis-related consumer packaged goods. It generates the majority of its revenue from the Wholesale Biomass segment.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: